Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Teresa Zyczynski"'
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 2, Iss 2 (2015)
**Background:** Docetaxel has been a standard of care for castration-resistant prostate cancer (CRPC) in the United States since 2004, yet little has been reported on its patterns of use in routine practice. To help understand these patterns, a retro
Externí odkaz:
https://doaj.org/article/af78ae7e785c4c59b409594d48c92c72
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:HSR22-184
Autor:
Catherine Davis, Teresa Zyczynski, Araceli Garcia-Gonzalez, Charles S. Cleeland, Mona Kamal, H. Lin, Robert Z. Orlowski, Qiuling Shi, Loretta A. Williams, Xin Shelley Wang
Publikováno v:
Supportive Care in Cancer. 29:467-475
Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burden, health status, and quality of l
Autor:
Florencio Calderon, John Michael Thomas, Michelle Fiander, David D. Stenehjem, Dao Tran, Teresa Zyczynski, Connor Willis, Diana I. Brixner, Beata Korytowsky
Publikováno v:
Oncotarget
// Connor Willis 1 , Michelle Fiander 1 , Dao Tran 2 , Beata Korytowsky 3 , John-Michael Thomas 3 , Florencio Calderon 3 , Teresa M. Zyczynski 3 , Diana Brixner 1 and David D. Stenehjem 1 , 2 1 Department of Pharmacotherapy, University of Utah, Salt
Autor:
Srikanth Gajavelli, Loretta A. Williams, Mauricette Michallet, Ron Paquette, Irene DeGutis, Ruediger Hehlmann, Jorge E. Cortes, Teresa Zyczynski, Michael J. Mauro, Ginny P Sen, Carlo Gambacorti-Passerini, Bengt Simonsson, Stuart L. Goldberg
Publikováno v:
American Journal of Hematology
SIMPLICITY (NCT01244750) is an observational study exploring tyrosine kinase inhibitor (TKI) use and management patterns in patients with chronic phase‐chronic myeloid leukemia in the US and Europe in routine clinical practice. Herein we describe i
Autor:
Hesham Mohamed, Teresa Zyczynski, Yuanxin Rong, Elisabetta Abruzzese, Loretta A. Williams, Susanne Saussele, Dong-Wook Kim, Javier Pinilla-Ibarz
Publikováno v:
Annals of Hematology
Chronic, low-grade adverse events are common in patients with chronic myeloid leukemia who are treated with imatinib. These events may decrease patient quality of life and adherence, and may ultimately contribute to a suboptimal response. Alternative
Publikováno v:
Journal of Clinical Oncology. 39:127-127
127 Background: Racial disparities in cancer care have received increased attention in recent years. One previously identified disparity is in the time to treatment initiation (TTI) – a factor closely associated with outcomes. While most research i
Autor:
J McKendrick, Catherine Davis, David Cella, Teresa Zyczynski, Ravi Vij, Antonio Palumbo, Abderrahim Oukessou, Amber Kudlac
Publikováno v:
Annals of Hematology
Treatment of relapsed/refractory multiple myeloma (RRMM) aims to prolong survival while maintaining health-related quality of life (HRQoL) by managing disease-related symptoms and complications—one of the most frequent and debilitating being bone p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4777a1be5ff8b83930418b88d73890
https://hdl.handle.net/10453/130893
https://hdl.handle.net/10453/130893
Autor:
John A. Rizzo, Peter J. Mallow, Geralyn C. Trudel, John R. Penrod, Jie Chen, Teresa Zyczynski
Publikováno v:
Journal of Occupational & Environmental Medicine. 58:351-358
The aim of the study is to estimate lost labor productivity costs of prostate cancer (PC) to patients and their spouses.This study used a nationally representative database from the United States, the Medical Expenditure Panel Survey, to estimate los
Publikováno v:
Therapeutic Advances in Hematology. 6:3-14
Survival has increased dramatically for patients with chronic phase chronic myeloid leukemia (CP-CML) using BCR-ABL targeted tyrosine kinase inhibitors, such that life expectancy is expected to approximate that of patients without CP-CML. Randomized